A Digital Self-management Program (Help to Overcome Problems Effectively) for People Living With Cancer: Feasibility Randomized Controlled Trial

Hayley Wright, Faith Martin, Wendy Clyne, Cain Clark, Gabriela Matouskova, Michael McGillion, Andy Turner

    Research output: Contribution to journalArticlepeer-review

    10 Citations (Scopus)
    99 Downloads (Pure)

    Abstract

    Background:
    We present the results of a feasibility, randomized waitlist control group (CG) parallel design study with a 1:1 allocation ratio. Participants were randomized into an intervention group (IG) or a waitlist CG. The intervention was a 6-week digital self-management program, Help to Overcome Problems Effectively (HOPE), for people with cancer.

    Objective:
    This study aims to test the feasibility of a digitally delivered self-management program for people with cancer. This will inform the design of a definitive randomized controlled trial. In addition, a preliminary assessment of the impact of the HOPE program via secondary outcomes will be used to assess signals of efficacy in a trial context.

    Methods:
    Participants were drawn from an opportunity sample, referred by Macmillan Cancer Support, and were invited via email to participate in the study (N=61). Primary outcomes were rates of recruitment, retention, follow-up, completion and adherence, sample size and effect size estimation, and assessment of progression criteria for a definitive trial. Secondary outcomes were self-report measures of participants’ positive mental well-being, depression, anxiety, and patient activation (ie, confidence in managing their cancer). The intervention and data collection took place on the web.

    Results:
    The recruitment rate was 77% (47/61). A total of 41 participants completed the baseline questionnaires and were randomized to either the IG (n=21) or the waitlist CG (n=20). The retention rate (attending all program sessions) was greater than 50% (all: 21/41, 51%, IG: 10/21, 48%; and CG: 11/20, 55%). The follow-up rate (completing all questionnaires) was greater than 80% (all: 33/41, 80%; IG: 16/21, 76%; and CG: 17/20, 85%). The completion rate (attending ≥3 sessions and completing all questionnaires) was greater than 60% (all: 25/41, 61%; IG: 13/21, 62%; and CG: 12/20, 60%). Engagement data showed that participants viewed between half (5.1/10, 51%) and three-quarters (12.2/16, 76%) of the pages in each session.

    Conclusions:
    All progression criteria for a definitive trial were met, as supported by the primary outcome data. The IG showed improved postprogram scores on measures of positive mental well-being, depression, anxiety, and patient activation. A full-scale trial of the digital HOPE program for people with cancer will allow us to fully evaluate the efficacy of the intervention relative to a CG.

    Trial Registration:
    ISRCTN Registry ISRCTN79623250; http://www.isrctn.com/ISRCTN79623250

    International Registered Report Identifier (IRRID):
    RR2-10.2196/24264
    Original languageEnglish
    Article numbere28322
    Number of pages17
    JournalJournal of Medical Internet Research
    Volume23
    Issue number11
    Early online date5 Nov 2021
    DOIs
    Publication statusPublished - 5 Nov 2021

    Bibliographical note

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/),
    which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the
    Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication
    on https://www.jmir.org/, as well as this copyright and license information must be included.

    Keywords

    • self-management
    • cancer
    • survivorship
    • digital cinema
    • positive psychology

    Fingerprint

    Dive into the research topics of 'A Digital Self-management Program (Help to Overcome Problems Effectively) for People Living With Cancer: Feasibility Randomized Controlled Trial'. Together they form a unique fingerprint.

    Cite this